| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851847 | American Journal of Kidney Diseases | 2008 | 10 Pages |
Abstract
Receipt of gadolinium-containing MRI contrast is associated with NSF in a dose-dependent manner. The risk associated with gadolinium may differ by contrast agent and dialysis modality. Use of gadolinium-based contrast agents should be avoided when possible in patients with renal failure.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alexander J. MD, MPH, Michael A. MD, MPH, Steven MD, Theresa DO, George MD, PhD, Liana MD, Matthew DrPH, Jeannette MD, Brian MD, PhD, Georges MD, Priti R. MD, MPH,